Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.

被引：0
|
作者：
Mackay, Christine B.
Hepler, Kerry
Erickson, Kirsten D.
Daley, Christine
机构：
[1] Univ Kansas, Canc Ctr 1, Fairway, KS USA
[2] Univ Kansas, Med Ctr 2, Fairway, KS USA
[3] Univ Kansas, Canc Ctr, Fairway, KS USA
[4] Univ Kansas, Med Ctr 1, Fairway, KS USA
[5] Univ Kansas, Canc Ctr 2, Fairway, KS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18174
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Global Oncology Projects at NCI-Designated Cancer Centers: A Focus on Implementation Science
    Frank, Allison
    Garton, Elise
    Eldridge, Linsey
    Cira, Mishka Kohli
    Duncan, Kalina
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (06)
  • [22] Assessing the missions and visions of NCI-designated cancer centers and their affiliated hospitals.
    Bouvette, Max Joseph
    Xing, Jiazhang
    Moore, Vanessa Ann
    Lam, Anh B.
    Jiang, Changchuan
    Choradia, Nirmal
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] The Financial Toxicity of Parking Fees for Radiation Treatment at NCI-Designated Cancer Centers
    Lee, A.
    Shah, K.
    Byun, J.
    Chino, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S99 - S99
  • [24] Engaging community members in cancer research: an assessment of an NCI-designated cancer center
    Leader, Amy E.
    Melillo, Rebecca J.
    Greene, Quincy
    Blanding-Godbolt, Joshua
    Shimada, Ayako
    Eischen, Christine M.
    Aplin, Andrew E.
    CANCER CAUSES & CONTROL, 2023, 34 (04) : 307 - 319
  • [25] Incorporating the Patient Voice: An Evaluation of NCI-Designated Cancer Centers and Patient Reported Experiences with Genomic Medicine
    Andriessen, Amanda S.
    Saulsberry, Loren
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [26] Identifying Neighborhoods with Cervical Cancer Disparities for Targeted Community Outreach and Engagement by an NCI-Designated Cancer Center: A Geospatial Approach
    Lee, Ming S.
    Elliott, Nancy S.
    Bethel, Valerie D.
    Balise, Raymond R.
    Kobetz, Erin N.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (10) : 1275 - 1283
  • [27] Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
    Angelin Tresa Mathew
    Bhav Jain
    Edward Christopher Dee
    Jordan Johnson
    Fumiko Chino
    Annals of Surgical Oncology, 2022, 29 : 3381 - 3383
  • [28] Blood cancer survivorship in NCI-Designated Cancer Centers: a study of services, gaps, and access barriers
    Reinhart, Crystal A.
    Sae-Hau, Maria
    Lee, Carol A.
    Weiss, Elisa S.
    JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (01) : 43 - 47
  • [29] Analysis of barriers to clinical trial accrual in an NCI-designated comprehensive cancer center: Results of identifying clinical trial gaps
    Dayao, Z.
    Nemunaitis, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers (vol 4, pg 992, 2017)
    Simoni, Zachary R.
    Martin, M. Y.
    Wenzel, Jennifer
    Cook, Elise D.
    Konety, Badrinath
    Vickers, Selwyn M.
    Chen, Moon S., Jr.
    Foaud, Mona N.
    Durant, Reagan W.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2017, 4 (05) : 999 - 999
12345